Parataxis Holdings invested $18.29 million to acquire a Korean company to build a Bitcoin financial platform.

RektRecovery · 2025-06-20T12:22:32+00:00

Parataxis Holdings has reached an agreement with Bridge Biotherapeutics to invest 25 billion Korean Won for a controlling stake, aiming to launch a Bitcoin financial platform in South Korea. The platform will be supported by institutional investors to promote digital asset management. The transaction will be listed after completing due diligence and other procedures.

RektRecovery

2025-06-20 12:22:32

Abstract generation in progress

[Chain News] PANews, June 20 - According to reports, the Bitcoin-focused investment startup Parataxis Holdings has announced that it has reached a final agreement with Bridge Biotherapeutics, Inc. to invest 25 billion Korean Won (approximately 18.29 million USD), giving Parataxis Holdings a controlling stake in the company to acquire the Korean Bridge Biotherapeutics, with the aim of launching an institution-backed Bitcoin financial platform in the Korean public market. This transaction will create a Bitcoin-native fund management platform in the Korean public market, supported by institutional investors with extensive experience in digital asset investment.

According to previous news, Parataxis Holdings plans to go public through a SPAC transaction, which still needs to complete the usual procedures such as due diligence, signing a final agreement, and obtaining regulatory approval.

BTC1,12%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

12 Likes